{"id":223040,"date":"2025-06-29T04:07:16","date_gmt":"2025-06-29T04:07:16","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/223040\/"},"modified":"2025-06-29T04:07:16","modified_gmt":"2025-06-29T04:07:16","slug":"when-will-genetically-modifying-our-children-go-mainstream","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/223040\/","title":{"rendered":"When Will Genetically Modifying Our Children Go Mainstream?"},"content":{"rendered":"

In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded<\/a> together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined practical steps that countries and research institutions could take to discourage this sort of experimentation, such as strengthening regulations tied to gene editing.<\/p>\n

\u201cGermline editing has very serious safety concerns that could have irreversible consequences,\u201d said Bruce Levine, a cancer gene therapy researcher at the University of Pennsylvania and former president of the ISCT, in a statement<\/a>. \u201cWe simply lack the tools to make it safe now and for at least the next 10 years.\u201d<\/p>\n

Newer technologies such as CRISPR have made gene editing easier, cheaper, and more practical to carry out in a variety of species, humans included. That reality has made heritable germline editing\u2014altering egg, sperm, and embryos such that they can be passed down to offspring\u2014more feasible than ever.<\/p>\n

In November 2018, Chinese scientist He Jiankui thrust<\/a> this issue into the limelight when he announced that his team modified the genes of several human embryos using CRISPR, then implanted them successfully in women volunteers. Eventually three children were born with the modifications, intended to confer natural immunity to HIV infection. He deliberately flouted ethical guidelines and the law in his research, such as doctoring lab results so that HIV-positive men could father the children (according to He, the children were born without HIV and appeared to have avoided any related health issues).<\/p>\n

He\u2019s experiments were roundly condemned by the scientific community and he ultimately served a three-year prison term for his actions, which ended in 2022. Upon release, He went back to working in the gene-editing field, though he promised<\/a> to abide by domestic and international rules. The episode showed that human heritable germline editing is already clearly possible today, but not necessarily ethical to carry out. Indeed, many scientists and bioethicists believe we\u2019re not ready to go down that path just yet.<\/p>\n

For this Giz Asks, we reached out to several bioethicists to get their take on the moratorium, and more broadly, on the question of when we should be able to genetically modify children, if ever.<\/p>\n

Arthur Caplan <\/p>\n

Founding head<\/a> of the Division of Medical Ethics at New York University\u2019s Grossman School of Medicine\u2019s Department of Population Health.<\/p>\n

\n

I\u2019ve been thinking about that question for well over 40 years.<\/p>\n

We didn\u2019t always have the technology to go in and modify genes in an egg, sperm, embryo, or fetus for that matter. But it\u2019s certainly the case that people have been thinking hard about trying to genetically alter and improve children, probably back to the Greeks<\/a>.<\/p>\n

We know that in modern times, Nazi Germany was home to race hygiene theory and a form of eugenics; they would have been very interested in creating better babies. They did have the Lebensborn Program<\/a> where they tried to force women and men that they deemed especially genetically fit to breed and have kids. It\u2019s not really clear whatever happened to those kids. But it\u2019s a form, if you will, of trying to get the right genes into your offspring and get them passed along into the future. They practiced that.<\/p>\n

And we had versions of that in the U.S., believe it or not. We actually had awards given at state fairs<\/a> to families that were seen as eugenically the best and trying to encourage those families to have bigger families. That\u2019s an idea that\u2019s still rattling around today, by the way, in the mouths of Donald Trump<\/a>, Elon Musk<\/a>, Stephen Miller<\/a>, etc. Many in the current Trump administration are very concerned<\/a> about minorities becoming the majority in the U.S.<\/p>\n

In any event, these are old fashioned ideas, often fueled by dreams of eugenics, shifting the population in the future toward healthier, more competent, more physically able people, trying to get people of the right race or ethnicity so that the society\u2019s makeup is proper. They don\u2019t rely on engineering a gene. There\u2019s no CRISPR. There\u2019s nobody going in there and trying to penetrate the cell wall to insert genetic information. But those are just new ways to think about ideas that have been around for a long time.<\/p>\n

So if you ask me, will we see genetic engineering of children aimed at their improvement? I say yes, undoubtedly. Now when? I\u2019m not sure what the answer to that is. Right now, we have some crude tools. We are seeing some efforts to use gene therapy in kids to repair diseases of their bodies, not things that would be inherited. They work a bit, but I wouldn\u2019t say we\u2019re really at the sort of utopia of being able to reliably get rid of in a person or a child, sickle cell or other major diseases. The tools, despite a lot of hype and a lot of maybe press release journalism, are not quite there yet to really say we can even do a good job repairing disease in an existing kid. So when it comes to trying to use tools to modify an embryo, I\u2019m going to say flat out we\u2019re at least 10 years away from that in any serious way that could be considered safe, targeted, and likely to produce the outcome you want. So the big restriction now is safety. I think we\u2019ll get past safety, but it is a reason right now not to do anything.<\/p>\n

Now, what else might become an objection if we did have accurate, sophisticated tools? I think the first is access. If you make better kids, but only some people can afford it, that wouldn\u2019t be fair. And that in itself would be unjust. And you might wind up creating two classes or more of humans on Earth, the genetically engineered superior people and others. And this obviously is a theme all over science fiction. Old-timers will remember the Wrath of Khan from Star Trek for their take on what happens when you get a super genetically engineered race. There\u2019s Gattaca, another movie that explored this. But I\u2019m going to say this somewhat controversially. Fairness in access never stopped a technology from going forward. When the rich and the middle class want it, they\u2019re not stopped by the fact that the poor can\u2019t get it. I would like to see provisions made to say we shouldn\u2019t move forward unless those technologies are available to those who want them regardless of cost. But I don\u2019t think that\u2019s going to happen. It\u2019s just never happened.<\/p>\n

So access is an issue, but I don\u2019t think it\u2019s a game-breaker for improving your kids. People also say, well, how will we improve? I mean, what\u2019s the best state? We can\u2019t agree on that. So will we really improve kids? There may be things we disagree about as to whether they\u2019re really improvements. Would it be an improvement to diminish pigment in black people? Try and make them less dark. We can certainly see that argued. There are plenty in the deaf community who say, well, deafness is not really something you have to get rid of or try to improve by genetically engineering hearing to make it better. They can get around the world deaf using a different language and different institutions.<\/p>\n

But there are clearly things that it would be nice to genetically improve in kids. Immunity would be great. We do it now with vaccines. It would be great to find the right genes, tweak them, and build stronger immune systems. It would be great to make sure that we try our best to diminish the extreme pain, that some of us suffer not just as disease, but with respect to certain stimuli. I\u2019m not saying we should genetically eliminate all pain. That would probably put us in danger, but we don\u2019t quite have to suffer the way we do. My point being, the fact that we don\u2019t agree on everything as to what would be an improvement doesn\u2019t mean that we can\u2019t agree on anything.<\/p>\n

The last thing I\u2019ll say is this. When you try to make better kids, I think one last concern is: Are you going to make the children have less options rather than more? So if I considered it an improvement in a child to make them a giant, or to make them a tennis player, or to try and figure out perhaps some weird appearance that would make them a celebrity, I\u2019m condemning the child to my choice. They don\u2019t have the freedom to run their own life. They don\u2019t have the ability to choose what they want to do. I tighten down their future by narrowing the kinds of traits they have. That, I think, is a legitimate objection. We have to think hard about that. Many of the things we do environmentally, learn to read better, learn to do exercise, learn to play games, these are skills that expand capacities in our children, and may in fact be values that are then passed on to future generations. But they don\u2019t wind up creating kids who are less capable because of those interventions. That\u2019s where genetic change has to be watched very closely.<\/p>\n

So the bottom line of this gigantic speech is yes, we will see genetic modification of our children. It will come. There are traits that people will eagerly try to put into their kids in the future. They will try to design out genetic diseases, get rid of them. They will try to build in capacities and abilities that they agree are really wonderful. Will we hang up these interventions on ethical grounds? For the most part, no, would be my prediction, But not within the next 10 years. The tools are still too crude.<\/p>\n<\/blockquote>\n

Marsha Michie <\/p>\n

Associate professor of bioethics<\/a> at Case Western Reserve University\u2019s School of Medicine<\/p>\n

\n

There are children with genetic modifications walking around today, children like KJ, who was treated with personalized CRISPR gene editing<\/a> at just six months old. There are now kids who are free of sickle cell disease symptoms through CRISPR therapy, the first one ever approved by the FDA. All of these children are \u201cgenetically modified,\u201d and they and their parents couldn\u2019t be happier about it. What other conditions could and should be treated through genetic modifications? That\u2019s a question that scientists are actively working on, and that social scientists like me are talking about with patients, parents, and communities\u2014because we and they think it\u2019s really important for them to be part of those decisions.<\/p>\n

These \u201csomatic\u201d gene editing treatments that are already being used aren\u2019t the kind that is passed down through our reproductive cells, the germline. Heritable gene modification would involve embryos, eggs, or sperm, or even possibly other cells that could be turned into these kinds of cells. A technology currently being researched, called in vitro gametogenesis<\/a>, could use gene editing to turn skin cells into reproductive cells, allowing families with infertility to have their own genetically related children.\u00a0And of course, there are scientists looking at the possibility of editing reproductive cells to allow couples who carry the genes for severe diseases to conceive children without those conditions.<\/p>\n

Many ethicists and scientists have drawn a hard line between heritable and non-heritable gene editing, but in practice it\u2019s not nearly so clear-cut. Off-target effects of gene editing are difficult to predict or control, so there is a chance that reproductive cells could be changed by treatments aimed at other organ systems. Fetal gene editing, which could help babies with some conditions be born with few or no symptoms, will also involve the pregnant bodies of their mothers; those adults could host edited cells even after the pregnancy ends, possibly affecting their future children too. Families dealing with genetic conditions that cause great suffering for their children don\u2019t necessarily see a problem with eliminating those conditions forever with heritable gene editing. On the other hand, some people living with genetic conditions, such as deafness or autism, see no reason for treating their condition with gene editing, heritable or not, because their biggest problems come not from the condition itself but from the way society treats them.<\/p>\n

So there are many questions to be asked about all forms of genetic modification, and how they will be developed and implemented. All the gene editing treatments that exist now or are being imagined over the next decade, heritable or not, involve exorbitant cost and will be inaccessible to most people worldwide. It will be crucial to balance the excitement of these novel technologies with attention to questions of justice, developing new treatments with an eye toward both accessibility and the priorities of those most affected<\/a>. The only way to do this is to bring more voices into conversation with one another: people living with genetic conditions, scientists and doctors, policymakers of all kinds, and members of the public. Although gene editing is an amazing tool to add to our kit, the work of building more robust healthcare and support for families carrying or living with genetic conditions doesn\u2019t begin or end with genetic modification.<\/p>\n<\/blockquote>\n

James J. Hughes <\/p>\n

Bioethicist, sociologist, and executive director<\/a> of the Institute for Ethics and Emerging Technologies.<\/p>\n

\n

Yes we should, when it\u2019s safe, effective, and voluntary.<\/p>\n

Calls to permanently ban the creation of genetically modified children often rest on fear, not facts. They mirror past moral panics over interracial marriage, in vitro fertilization, and birth control\u2014all technologies or choices once deemed unnatural or dangerous, and now widely accepted. We should be wary of arguments dressed up as ethics but rooted in anxiety about change.<\/p>\n

That doesn\u2019t mean anything goes. Like any powerful technology, gene editing must be tightly regulated for safety and efficacy. But the agencies we already trust to regulate medicine\u2014the FDA, NIH, and institutional review boards\u2014are largely capable of doing that. We don\u2019t need a bioethics priesthood or a new bureaucracy to police reproductive decisions. We need science-based oversight, individual consent, and protection from coercion.<\/p>\n

One of the loudest objections to genetic editing is the specter of \u201ceugenics.\u201d But if eugenics means state control over reproduction, then the lesson of the 20th century is to defend reproductive freedom, not curtail it. Governments should not tell parents what kinds of kids to have. Preventing parents from using safe, approved gene therapies to reduce suffering or enhance their children\u2019s lives is a strange way to honor that lesson. They should give parents access to all the information and technology for the choices they make. True reproductive liberty includes the right to use the best science available to ensure a child\u2019s health.<\/p>\n

Another objection is that genetic modification could harm people who would rather not participate. But this \u201cperfection anxiety\u201d ignores how all medical advances shift social norms. We didn\u2019t stop improving dental care because it made bad teeth less acceptable. And a healthier society has not led to less compassion for those who remain sick or disabled\u2014if anything, it\u2019s strengthened the case for inclusion and support. The goal should be equitable access, not frozen norms.<\/p>\n

We do need to ensure that parents can access all the gene therapies that actually provide potential benefits for children. Governments with universal healthcare will need to make tough choices about what to cover and what not to cover. For instance, the National Health Service should make gene therapy to remove lethal, painful conditions available for all Britons, but parents may need to pay for medical tourism to some offshore clinic if they want to tweak their embryo\u2019s eye color.<\/p>\n

What about risks we can\u2019t foresee? Of course there will be some. All new medical therapies come with uncertainties. That\u2019s why we have trials, regulation, and post-market surveillance. There\u2019s no reason genetic therapies should be held to an impossibly higher standard. We should start with animal models, and proceed to the most morally defensible gene tweaks, lethal and painful conditions. Over time, as the safety of the techniques are better understood, we can expand the scope of therapeutic choices.<\/p>\n

Some worry that genetically modified children could disrupt our ideas of family or humanity. But those concepts have already been revolutionized\u2014by urbanization, feminism, economic precarity, and social movements. The family of today would be unrecognizable to most people in 1800. If genetic technologies change our values again, it won\u2019t be the first time. Liberal democracies don\u2019t freeze culture in place\u2014they ensure people have the freedom to shape it.<\/p>\n

Ultimately, the question isn\u2019t whether we should allow genetically modified children. It\u2019s whether we trust parents to make mostly good choices under the oversight of regulators and doctors. We should, because most parents have their children\u2019s best interests in mind, as they perceive them. That\u2019s why we allow parents to raise their own children in the first place. And we should ensure those choices are equitably available to all, not outlawed out of fear.<\/p>\n

If we ever find genetic tweaks to reduce suffering, enhance capability, or prevent devastating disease\u2014and we can do so safely and ethically\u2014the real moral failure would be to prohibit it.<\/p>\n<\/blockquote>\n

Kerry Bowman <\/p>\n

A Canadian bioethicist and environmentalist currently teaching<\/a> at the University of Toronto.<\/p>\n

\n

Well, there\u2019s a big difference between genetic enhancement and treatment. And with enhancement, I think we\u2019re nowhere near a point where we should be even considering that. But with treatment, the large ethical issue right now is something like single gene mutation. So something like Huntington\u2019s disease, muscular dystrophy, or similar diseases, could it be justified to edit the gene for that?<\/p>\n

The challenge is we don\u2019t fully understand all the things. We don\u2019t know what we don\u2019t know, to put it bluntly. And with germline editing, the changes we would be making are permanent and they run through many generations ahead. So, yes, being able to prevent deadly or debilitating illnesses is absolutely something wonderful. But having said that, you obviously don\u2019t have consent of the person who will be born, but you also don\u2019t have consent of the generations that come after that. And if there is complications or unexpected problems, you can have an inheritance that just keeps running through generations.<\/p>\n

But here\u2019s the thing with this moratorium; to what end? You can call for a moratorium, but if no one\u2019s focusing on anything, if there\u2019s no research, no planning, no social discourse, there\u2019s just a lot of people with different opinions, and everything gets shelved for 10 years. I\u2019m not sure that\u2019s going to be particularly useful. It sounds great if it\u2019s going to be 10 concentrated years on building consensus and public engagement and those types of things, but I don\u2019t think that\u2019s what would actually happen.<\/p>\n

And also, I\u2019m sure you\u2019ve noticed, the world\u2019s not in good shape, and Western culture is not of one mind these days. And with the ruptures, particularly in the United States, there\u2019s a lot of division in Western culture of how people see things. And I\u2019m just not convinced that a moratorium, that people would make use of it in a constructive way. It really needs a coordinated plan, and I\u2019m not sure there is one. So I do see that as quite a problem.<\/p>\n

The other thing is, we\u2019re dealing with high-income countries. So when we look at potential for CRISPR-Cas9 and gene editing, we\u2019re dealing with a very small percentage of the world\u2019s population. I\u2019m going to guess that it\u2019s maybe 15% to 20% of the world\u2019s population, because most of the population of the world has no access to things like this and never will. Not never will, but in the foreseeable future, they won\u2019t. And I think that\u2019s something we miss a lot of the time. And the biggest ethical problem in the world today is not gene editing. It\u2019s just access to healthcare. And this doesn\u2019t do anything in those domains whatsoever. So from a justice point of view, that is a concern.<\/p>\n

And I\u2019m going to sound cynical here. Emerging medical technologies are not motivated largely by the social sector. They\u2019re motivated by marketing and market forces. So if people can make money on this, somehow, someway, people will proceed. And if gene editing is illegal in Canada and the U.S. and Western Europe and Australia, there\u2019s a lot of countries that don\u2019t fall into that. And you can set up shop anywhere. Equatorial Guinea or other places are not going to be worried about things like this. They\u2019ve got enough problems on their hands. And there\u2019s a lot of countries out there where this would not be easily called.<\/p>\n

So I support the essence of it. And I can see why people want to do it. I\u2019m just not convinced it\u2019s all that feasible. I think what makes more sense is just not having any germline editing until we have a larger consensus about this technology.<\/p>\n<\/blockquote>\n

\n

\u00a0<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together…\n","protected":false},"author":2,"featured_media":223041,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[14192,35234,267,88035,70,16,15],"class_list":{"0":"post-223040","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-crispr","9":"tag-gene-editing","10":"tag-genetics","11":"tag-giz-asks","12":"tag-science","13":"tag-uk","14":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114764686649723641","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/223040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=223040"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/223040\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/223041"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=223040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=223040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=223040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}